Don’t miss out on Anthem’s commission programs
Anthem announced a new Special Agent Commission Program which is available to all agents. This Special Agent Commission Program is for December 1st and December 15th, 2020 effective dates and will consist of a 7% Commission Rate.
Here’s how to determine Group/Membership Eligibility:
Small Group must consist of 10+ enrolled employees.
Only Small Groups with 10 or more enrolled employees on Anthem plans with an effective date of December 1, 2020, or December 15, 2020, will be eligible for this program.
New Small Business Group employees are those who have the same enrollment effective date as the employer group’s original Anthem effective date. For example, if an employer group’s original effective date is December 1, 2020, then the members must also have an effective date of December 1, 2020
Commission percentage is based on the number of enrolled employees with Anthem medical plans
Appointed agents must be in good standing with a current, signed Anthem agent contract and valid license on file
And through November, Anthem’s Medical Agent Commission Program gives agents the opportunity to earn a 6% commission rate.
Business sold through a General Agent partner is eligible for this program!
For full details on how the Special Agent Commission Program works, check out this flyer.
For more information on the Medical Agent Commission Program, check out this flyer.
Please reach out to your Dickerson Account Executive for additional information.
ChoiceBuilder providing premium holiday on behalf of Delta Dental
To provide support and financial relief to employers and members during COVID-19, ChoiceBuilder, on behalf of Delta Dental, is providing a premium holiday for groups’ Delta Dental June 2020 premium.
ChoiceBuilder applied this one-time 100% credit for all members enrolled on Delta Dental PPO and DeltaCare USA plans during the month of June to existing groups’ October 2020 invoices.
This credit is part of Delta’s COVID-19 related premium forgiveness program. New business groups effective June or later and terminated groups do not qualify.
Broker commissions will not be impacted by this premium holiday.
For all pertinent details, please contact your Dickerson Account Executive.
Kaiser Permanente and Dickerson: expanding our partnership to better serve you
We are excited to expand our partnership with Kaiser Permanente (KP) to better serve our brokers.
Effective October 1, 2020, you can access Dickerson’s full support in providing KP for large groups and you’ll earn the full commission.
Offering KP will be easier than ever before with the extended variety of service options Dickerson provides. Our Sales Team is committed to offering viable solutions for any-size case. Our guiding principles inform all of our decisions, which is why we’re able to work as well as we do with each other and with our broker partners.
Kaiser Permanente and Dickerson are also hosting an exclusive webinar for brokers and their clients, Helping Employees Return to Work. This webinar will feature KP Physician Advisor Dr. Deb Friesen MD, MBA, FACP, who is an expert in conducting and helping employers return to work safely.
Helping Employers Return to Work Webinar: Tuesday September 15, 9:00 – 10:00 AM PST
Click here to register.
We want to invite brokers and their clients to this webinar and empower brokers to be able to assist clients with navigating and planning for the next normal at work. We strongly encourage you to invite your clients!
For more information, please contact your Dickerson Account Executive.
Dickerson News Update
Ways to help clients who lose their group coverage
Due to the coronavirus pandemic, many people have lost employer-sponsored health coverage. What happens when clients lose group coverage? They have the option to switch to individual coverage, which means new needs and new options.
Navigating market options can be overwhelming for people, which is why it’s important for insurance agents to be trusted advisors on both group and individual coverage. When insurance agents adjust quickly, these former group coverage leads can turn into individual health insurance sales.
Click here to learn more.
AstraZeneca COVID-19 vaccine study put on hold
The phase 3 study for the COVID-19 vaccine being developed by AstraZeneca and the University of Oxford has been put on hold due to a serious adverse reaction in a participant in the United Kingdom. Clinical holds are not uncommon, but it’s unclear how long AstraZeneca’s might last. This is the first Phase 3 COVID-19 trial known to be put on hold of the nine Phase 3 trials which are currently underway.
For the full story, click here.
California might enter generic drug market
The Democratic-controlled state legislature overwhelmingly passed SB-852, which might make California the first state to develop its own line of generic drugs. The state’s top health agency would partner with one or more drug companies to make or distribute generic or biosimilar drugs that are cheaper than brand-name products. This is a measure meant to provide options in a drug market dominated by pharmaceutical companies.
Though it might take years to successfully bring California generic drugs to the market, if done so successfully, the state would be in direct competition with major generic and brand-name drug manufacturers. California could then use its purchasing power to drive down drug prices.
Click here for the full story.